bone morphogenetic proteins - from local to systemic theraputics - s. vukicevic, et. al.,...
Post on 11-Sep-2021
2 Views
Preview:
TRANSCRIPT
Series Editor
Prof. Michael J. Parnham PhDDirector of Preclinical DiscoveryCentre of Excellence in Macrolide Drug DiscoveryGlaxoSmithKline Research Centre Zagreb Ltd.Prilaz baruna Filipovica 29HR-10000 ZagrebCroatia
Progress in Inflammation Research
Forthcoming titles:
Angiogenesis in Inflammation: Mechanisms and Clinical Correlates, M.P. Seed, D.A. Walsh (Editors), 2008
New Therapeutic Targets in Rheumatoid Arthritis, P.-P. Tak (Editor), 2008Inflammatory Cardiomyopathy (DCM) – Pathogenesis and Therapy, H.-P. Schultheiß,
M. Noutsias (Editors), 2008Matrix Metalloproteinases in Tissue Remodelling and Inflammation, V. Lagente, E. Boichot
(Editors), 2008Microarrays in Inflammation, A. Bosio, B. Gerstmayer (Editors), 2008Occupational Asthma, T. Sigsgaard, D. Heederick (Editors), 2008Nuclear Receptors and Inflammation, G.Z. Feuerstein, L.P. Freedman, C.K. Glass (Editors),
2009
(Already published titles see last page.)
Advisory Board
G. Z. Feuerstein (Wyeth Research, Collegeville, PA, USA)M. Pairet (Boehringer Ingelheim Pharma KG, Biberach a. d. Riss, Germany)W. van Eden (Universiteit Utrecht, Utrecht, The Netherlands)
vukicevic.indd ii 16.4.2008 11:17:01 Uhr
∞
μ
β
β α
≤
β β
ββ
× ×
β
β
β
ββ
ββ
β
β
≥
μ
μ
≤
×
≤
× × × ×
≤
×
×
×
××
≤
×
×
≤
β
ββ
α β
ββ
β
β
β
β
β
β
β β
κ
α
β
β
β
β
β
β β
Δ
Δ
Δ Δ
Δ Δ
Δ Δ Δ
Δ
Δ Δ Δ Δ
Δ Δ
Δ
Δ Δ Δ Δ
ββ
β
β
β
ββ
β
β β ββ
ββ
β
β
β
β
β
β
κ κ
κ
κ
β
×
××
× ×
××
×
×
β
β
β
β
β
β
β
β
ββ
β
β β
β
β
β
β
β
μ
μμ
μμ
μμ
μ
μ μ
μ μ
μ
μ
μ
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β
β β
β
β
βα α
β
β
β
α
κ
β
β κκ α
κ βκ κ
βκ
β
β κ κ α
β κβ
β
ββ
β
β
β
β
β α
β
β
β
β α
β
β
ββ
β
×
κ
β
μ
μ
× × μ
μ
μ
μ
μ μ
μ
μ
α β
×
ββ
β
β
β
β
β
β
β
β
β β
β
μ ×μ × μ ×
β
β
β
ββ
≥
ββ β
μ
β
β
μμ
μ
β
μ μ
β
μ
α β
β β
β
β
β
β β
β
β
β
×
β
β
β
κ
β β
α α
β
top related